 |
인쇄하기
취소
|
Arbitration-based non-exclusive license on Glivec eyed
The arbitration-based non-exclusive license (ANEL) on Glivec is now emerging as a hot issue, amid the prolonged showdown on its pricing among the interested parties.
According to the Joint Countermeasure Committee of Glivec Settlement and Expanded Publicity of Drugs (JCC), the representatives from the JCC and chronic myeloid leukemia (CML) patients are scheduled to visit two promising pharma...
According to the Joint Countermeasure Committee of Glivec Settlement and Expanded Publicity of Drugs (JCC), the representatives from the JCC and chronic myeloid leukemia (CML) patients are scheduled to visit two promising pharma...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.